Abstract |
Cinnamaldehyde from the bark of Cinnamomum cassia has been reported to have antitumor activity mediated by the inhibition of farnesyl transferase. We assessed in vivo the chemo-preventive effect of cinnamaldehydes on H-ras12V-induced hepatocellular carcinoma formation. A mouse model of hepatocellular carcinoma was established by using the transgene of mutated H-ras12V under the regulation of albumin enhancer/promoter. When treated with cinnamaldehyde for 10 weeks, hepatic tumor development was delayed with 2'-benzoyloxycinnamaldehyde (BCA) compared with control hepatocellular carcinoma formation. The effect of 2'-hydroxycinnamaldehyde (HCA) was comparable. The number of lesions and the size of each lesion were significantly reduced by BCA. Cell proliferation in the lesion was detected by incorporation of 5-bromo-2'-deoxyuridine ( BrdU). BCA increased the number of splenocytes, concanavalin A-stimulated splenocyte proliferation and the infiltration of lymphocytes into liver. Data suggest that the delayed hepatic tumor development observed with BCA could be mediated by a long-term immunostimulating effect on T cells.
|
Authors | Eun-Yi Moon, Mi-Ran Lee, Ai-Guo Wang, Jun-Hee Lee, Hyoung-Chin Kim, Hwan-Mook Kim, Jin-Man Kim, Byoung-Mog Kwon, Dae-Yeul Yu |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 530
Issue 3
Pg. 270-5
(Jan 20 2006)
ISSN: 0014-2999 [Print] Netherlands |
PMID | 16405947
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 2'-benzoyloxycinnamaldehyde
- Antineoplastic Agents
- Antineoplastic Agents, Phytogenic
- Benzoates
- Acrolein
- cinnamaldehyde
|
Topics |
- Acrolein
(analogs & derivatives, pharmacology)
- Animals
- Antineoplastic Agents
(pharmacology)
- Antineoplastic Agents, Phytogenic
(pharmacology)
- Benzoates
(pharmacology)
- Carcinoma, Hepatocellular
(drug therapy, genetics, pathology)
- Cell Proliferation
(drug effects)
- Female
- Genes, ras
(genetics)
- Hepatocytes
(drug effects, metabolism)
- Liver Neoplasms, Experimental
(drug therapy, genetics, pathology)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- NIH 3T3 Cells
- Spleen
(cytology)
- Tumor Burden
(drug effects)
|